THE EFFECT OF CALISTHENIC EXERCISES ON FATIGUE AND EXERCISE ATTITUDES IN PATIENTS WITH LUNG CANCER
NCT ID: NCT07237503
Last Updated: 2025-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
33 participants
INTERVENTIONAL
2025-07-15
2026-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examination Of Exercise Adherence İn Lung Cancer Patients Given Calisthenic Exercise
NCT05332171
Fit for Everyday Life - Increasing Exercise and Physical Activity in Those Rehablilitating From Cancer
NCT05403671
Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience
NCT03724331
Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients
NCT01786122
Effect of Breathing Exercises on Pain, Dyspnea, and Function in Terminal-Stage Cancer Patients
NCT07164352
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
In the Physiotherapist-Led Exercise group, the exercise sessions were conducted under the supervision of a physiotherapist, and patients' respiratory rate, fatigue severity, blood pressure, and pain were regularly monitored.
In the Home Exercise Training group, the same exercises were demonstrated practically during the first session, and patients were instructed to re
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physiotherapist-Led Exercise
Patients in Group 1 were exercised 3 days a week for 8 weeks at 50-60% of maximal heart rate for 40 min, accompanied by a physiotherapist.
Exercise
Patients in Group 1 were exercised 3 days a week for 8 weeks at 50-60% of maximal heart rate for 40 min, accompanied by a physiotherapist.
Home Exercise Group
. Patients in Group 2 were given an exercise booklet and followed up with weekly controls.
Home based exercise
Patients in Group 2 were given an exercise booklet and followed up with weekly controls.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Patients in Group 1 were exercised 3 days a week for 8 weeks at 50-60% of maximal heart rate for 40 min, accompanied by a physiotherapist.
Home based exercise
Patients in Group 2 were given an exercise booklet and followed up with weekly controls.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with lung cancer who continue to receive chemotherapy, radiotherapy or immunotherapy (smart drugs)
* Patients reporting fatigue of 3 or more on the Modified Borg Scale
Exclusion Criteria
* Any acute infection at the time of assessment
* Those with orthopaedic, neurological, psychological, etc. problems that may limit the assessments
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hasan Kalyoncu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kardelen HATIMOĞULLARI
specialist physiotherapist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hasan Kalyoncu Üniversitesi
Gaziantep, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025/051
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.